Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
The synthetic drugs market in the Near and Middle East remains dynamic, following disruptions in the supply of “captagon”.The Near and Middle East accounted for 77 per cent of global “captagon” seizures in 2020–2024, with production mainly in the Syrian Arab Republic and Lebanon and trafficking…
Methamphetamine-related harms show mixed trends across North America.In Mexico, methamphetamine harms have increased in recent years, reflected in a growing number of people entering drug-related treatment for the substance – though recent data suggest possible signs of stabilization.In contrast,…
Seizures of methamphetamine in Asia continue to rise, even as the reported number of dismantled methamphetamine laboratories declines.Methamphetamine seizures in Asia reached a record high in 2024, while the number of dismantled (and reported) methamphetamine laboratories declined to its lowest…
Seizures of methamphetamine continued rising in South-East Asia while declining in East Asia.The largest quantities of methamphetamine worldwide were seized in East and South-East Asia, accounting for 48 per cent of the world’s total in 2024.Seizures of methamphetamine have been declining over the…
Methamphetamine seizures now dominate overall seizures of amphetamine-type stimulants (ATS) in the Near and Middle East/South-West Asia.Until 2022, ATS seizures in the subregion were dominated by amphetamine – notably “captagon” – but methamphetamine seizures have continued to rise since while…
Following a major upward trend over the last two decades, methamphetamine seizures in North America declined over the 2021-2024 period.
In parallel to declines in the quantities of methamphetamine seized in recent years, there have been ongoing declines…
